I’ve reviewed thousands of companies over the past 33 years in global markets, but none capture the imagination the way Ekso Bionics Holdings Inc. (OTCBB: EKSO) does.

The tiny exoskeleton maker just reported earnings and, as you might expect, there’s broad-based growth in every metric that matters from revenue, to staffing, to new contracts, to overseas expansion. You name it.

But there’s something the media isn’t covering.

Ironically, it’s the single most important factor in what I believe will ultimately be an exceptionally bright future for the company and savvy investors alike.

Here’s why there’s more upside for Ekso than any analyst will tell you.

7 Doubles in a Row Put the Odds in Your Favor

We spend a lot of time talking about the importance of lining your money up with Unstoppable Trends for one simple reason: doing so puts the odds of success in your favor.

Sadly, millions of investors do this backwards. They latch on to a promising young company making the latest gee-whiz-bang product and hope it’ll catch on. Some do. Most don’t.

Remember Everpix?

The company developed a simple, elegant photo-sharing service that was named a runner up at Tech-Crunch in 2011. It was better than most offerings today, yet failed because its founders were so focused on making the “perfect” product that they neglected their primary markets.

Or Plancast?

That company developed a social application intended to allow users to share social details with their friends. Only trouble was people are very private when it comes to actual plans and RSVPing.

Flying cars, the knowledge pill of the 1960s, and even nuclear bombs for excavation as a part of massive construction plans like damming the Amazon River! Gone, gone, and never made it, thank goodness!

My point is that every single one of those failed ventures started with a promising technology then had to find a market or a use that the companies themselves had to create.

Ekso, on the other hand, is doing the reverse. Like many of the world’s top companies, CEO Nathan Harding and his team identified a need first. Now they’re building out a suite of products to meet it.